Small Molecules

Big pharma, vulnerable supply chains, and an international religious network…

What trends and new technologies await the pharma industry in 2018 and beyond?

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.

We need to explore the chemical space outside of Lipinski’s rules.

A half-century-old “bet hedging” hypothesis explains the effectiveness of many drug combinations.

Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?

London’s Science Museum highlights superbugs and the stars that fight against them in a new exhibition.

Some patients, particularly children, find medicines unpalatable – and genetics could be the cause.

The year 2018 will be one of yet more drug approvals, but which areas will be neglected?

How a customer focused mission to boost single-use assembly product quality and supply security led to the Mobius® MyWay Program and a manufacturing site transformation.